Clinical Trial

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

Study acronym: POLUS
Recruiting
View on ClinicalTrials.gov →
Summary
In this non-interventional study, the effectiveness and tolerability of Lusefi® in adult patients with type 2 diabetes will be evaluated.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-01
Trial Details
NCT Number NCT07433192
Lead Sponsor Servier Russia
Conditions Type 2 Diabetes Mellitus
Enrollment 300 participants
Start Date 2026-03-02
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-30